Syndax Pharmaceuticals CFO buys 1,219 shares, CEO sells 7,412 shares at $20.62 each.

Syndax Pharmaceuticals Inc. has announced that Chief Financial Officer, Goldan Keith A., has recently made a purchase of 1,219 shares at a price of $8.48 per share on January 30, 2026. Additionally, on February 6, 2026, Director and Chief Executive Officer, Michael A. Metzger, sold 7,412 shares at a price of $20.62 per share. Furthermore, on the same date, Chief Financial Officer Goldan Keith A. sold 2,082 shares at a price of $20.62 per share.